Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic-based transmission analysis of carbapenem-resistant Pseudomonas aeruginosa at a tertiary care centre in Cologne (Germany) from 2015 to 2020

3 May 2022

Abstract excerpt

Abstract Objectives To describe the propensity of carbapenem-resistant Pseudomonas aeruginosa to spread within a hospital critical care setting. Methods The study was conducted in a 700-bed tertiary centre in Cologne, Germany. P. aeruginosa resistant to piperacillin, ceftazidime, cefepime, imipenem, meropenem and ciprofloxacin, isolated from clinical and screening specimens from four critical care units from 2015...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35611260
DOI: 10.1093/jacamr/dlac057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic-based transmission analysis of carbapenem-resistant Pseudomonas aeruginosa at a tertiary care centre in Cologne (Germany) from 2015 to 2020PMID 35611260Read ↗

Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany.Semantic proximity Read ↗

Comparative genome analysis of carbapenemase-producing Pseudomonas aeruginosa: gene diversity, clonal distribution, and genome dynamics.Semantic proximity Read ↗

Emergence of a novel carbapenem-resistant Pseudomonas aeruginosa sequence type (ST) 5380 causing a hospital outbreak in Northern Italy, May to September 2024Semantic proximity Read ↗

Genomic Characteristics and Risk Factor Analysis of Carbapenem-non-susceptible pseudomonas aeruginosa Causing Bacteremia in a Tertiary Hospital (2014-2023)Semantic proximity Read ↗

Import of global high-risk clones is the primary driver of carbapenemase-producing Pseudomonas aeruginosa in Norway.Semantic proximity Read ↗

Genotypic and Phenotypic Landscape of Carbapenem-Resistant Pseudomonas aeruginosa Isolated From Respiratory and Non-Respiratory Samples in a Tertiary HospitalSemantic proximity Read ↗

Mechanisms of and risk factors for in vivo evolution of carbapenem resistance in Pseudomonas aeruginosa causing lower respiratory tract infections.Semantic proximity Read ↗

Molecular characterization of carbapenemase-encoding genes in carbapenem-resistant Pseudomonas aeruginosa isolated from clinical samples in Yaoundé, Cameroon.Semantic proximity Read ↗

Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam inPseudomonas aeruginosaisolates recovered from ICU patients in Spain and Portugal depicted by WGSSemantic proximity Read ↗

Retrospective Data Insight into the Global Distribution of Carbapenemase-Producing Pseudomonas aeruginosaSemantic proximity Read ↗

Global phylogeography and genetic characterization of carbapenem and ceftazidime-avibactam resistant KPC-33-producing Pseudomonas aeruginosaSemantic proximity Read ↗

Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical careSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.